Nichd Neonatal Research Network
Clinical trials sponsored by Nichd Neonatal Research Network, explained in plain language.
-
Could a simple shot boost premature babies' brain power?
Disease control CompletedThis study tested whether giving premature babies a drug called darbepoetin (Darbe) weekly soon after birth could improve their brain development and reduce the need for blood transfusions. The trial included 650 very preterm infants born between 23 and 28 weeks of pregnancy. Res…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Could a heart drug save babies with a rare birth defect?
Disease control CompletedThis study tested a drug called milrinone in 66 newborn babies with congenital diaphragmatic hernia (CDH), a condition where a hole in the diaphragm allows organs to move into the chest, making it hard for the lungs to develop and work. The goal was to see if milrinone could safe…
Phase: PHASE2 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Blood transfusion showdown: which strategy helps tiniest babies survive and thrive?
Knowledge-focused CompletedThis study looked at whether giving more blood transfusions (liberal strategy) to extremely low birth weight babies (under 2.2 pounds) helps them survive and develop better than giving fewer transfusions (restrictive strategy). Over 1,800 babies from NICUs across the U.S. took pa…
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Knowledge-focused
Last updated May 26, 2026 12:01 UTC